Drug recall
Recovered Plasma
FDA recall event 28069 · Class II · Central California Blood Center
Key facts
| Event ID | 28069 |
|---|---|
| Recall numbers | B-0765-4, B-0766-4 |
| Recalling firm | Central California Blood Center |
| Product type | Biologics |
| Products | Recovered Plasma, Red Blood Cells Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, collected from a donor who was at increased risk for new variant Creutzfeld-Jakob Disease (nvCJD), were distributed. |
| Initiation date | Apr 4, 2003 |
| Termination date | Feb 27, 2004 |
| City | Fresno |
| Country | United States |
| FEI number | 2970324 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports